Temporal and sequential pattern of Alzheimer’s disease (AD) biomarkers presents a framework for in-vivo staging of disease progression.
Accumulated evidence supports the temporal and sequential patterns proposed by the original model and further modify it.
A hypothetical model of AD biomarkers proposed a framework for in-vivo staging of the disease. The model focused on established biomarkers of AD indicative of amyloid b (Ab) deposition and neurodegeneration.
The model incorporated principles based on the available data at the time.
The abnormal rate of AD …
Join today for instant access to all PsychU content, events, and more!
Membership is free!
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.